Baixar PDF

Outros usuários também visualizaram estes artigos

Experience using Imatinib and then Nilotinib, as second line, in patient with chronic myeloid leukemia and previous bariatric surgery. A case report Renato Centrone; Marcelo Bellesso; Debora Bonito; Daniela Dias; Rodrigo Santucci; Milton Aranha; Adelson Alves;
Hematol Transfus Cell Ther. 2020;42:373-5
Challenges in the production of COVID-19 convalescent plasma- analysis of donor recruitment Eliseo Joji Sekiya; Marcelo Bellesso; Adelson Alves;
Hematol Transfus Cell Ther. 2021;43:382-4
THE OUTCOME OF PERIPHERAL T-CELL LYMPHOMA PATIENTS FAILING FIRST-LINE THERAPY, FROM PROSPECTIVE COHORT OF T-CELL BRAZIL PROJECT Carmino De Souza; Eliana Miranda; Jamila Tavares; Renata LR Baptista; Karin C Cecyn; Juliana Pereira; Marcelo Bellesso; Samuel S Medina; Davimar Borducchi; Frederico L Nogueira; Daniela FC Farias; Thais Fischer; Rony Schaffel; Massimo Federico; Carlos S Chiattone;
Hematol Transfus Cell Ther. 2023;45 Supl 3:S13-4